Korean Registry of Non-Small Cell Lung Cancer Patients with EGFR Mutation

NCT06247280 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 2001

Last updated 2024-12-06

No results posted yet for this study

Summary

Korean Registry of Non-Small Cell Lung Cancer Patients with EGFR mutation to collect and analyze the patient's clinical features, diagnosis, and treatment results.

Conditions

Sponsors & Collaborators

  • The Korean Academy of Tuberculosis and Respiratory Diseases

    collaborator OTHER
  • Yuhan Corporation

    lead INDUSTRY

Principal Investigators

  • Sae Young Lee · Yuhan Corporation

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-24
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06247280 on ClinicalTrials.gov